Abstract 15107: Clinical Features, Hemodynamics and Outcomes of Pulmonary Hypertension in Adults with Congenital Heart Disease and Heart Failure with Reduced Ejection Fraction
Abstract
Background: Although pulmonary hypertension (PH) and heart failure (HF) with reduced ejection fraction (HFrEF) occur in adults with congenital heart disease (CHD), the relationship between PH and HFrEF has not been systematically studied in this population. We sought to define the clinical characteristics, hemodynamics, and outcomes of PH in CHD patients presenting with HFrEF. Methods: Retrospective study of adults with CHD, and systemic left ventricular EF ≤40% who underwent right heart catheterization. PH was defined and classified as pulmonary arterial hypertension (PAH), isolated post-capillary PH (IpcPH) and combined pre and post-capillary PH (CpcPH) using these criteria: mean pulmonary artery pressure (mPAP) 20, pulmonary vascular resistance 2.0 WU, PA wedge pressure 15 mmHg. HF therapy optimization was assessed using the guideline directed medical therapy (GDMT) score at baseline and 1-year follow-up. Results: Of 252 patients (age 43±17 years, 58% males), 73% had PH. Among patients with PH, 27%, 26%, and 47% had PAH, IpcPH, and CpcPH, respectively. There was no difference in survival between the 3 groups. However, PH severity, specifically mPAP ≥25 mmHg was associated with mortality. The patients who received greater GDMT uptitration had greater improvement in cardiac function less neurohormonal activation, and higher survival compared to those who received less GDMT uptitration. Conclusion: PH is common in patients with CHD and HFrEF and is associated with increased mortality. Further studies are required to delineate the role of GDMT in the prevention and treatment of PH in this population, and to explore whether pulmonary vasodilators would be beneficial in the subset of patients with isolated PAH.